nderstanding the basis of reduced incidence of skin cancers in vitiligo andunderstanding the role of MALAT-1
Not Applicable
- Conditions
- Health Condition 1: L80- Vitiligo
- Registration Number
- CTRI/2024/04/065885
- Lead Sponsor
- Dr. D.Y. Patil Medical College, Hospital and Research centre,, Pune
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Closed to Recruitment of Participants
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients diagnosed with stable (6months) non-segmental vitiligo
Exclusion Criteria
Pregnant or lactating women
Active infection
Suffering from other autoimmune diseases
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To investigate the reduced incidence of skin cancers in vitiligoTimepoint: 2years
- Secondary Outcome Measures
Name Time Method understand the role of MALAT-1 in development of skin cancers in vitiligoTimepoint: 2 years